Literature DB >> 17410027

Clinical characteristics and survival of patients with surgically resected, incidentally detected lung cancer.

Dan J Raz1, David V Glidden, Anobel Y Odisho, David M Jablons.   

Abstract

BACKGROUND: There is little information on the clinical characteristics and outcomes of patients with surgically resected, incidentally detected lung cancers. Our hypothesis was that among patients with surgically resected non-small cell lung cancer (NSCLC), incidentally detected cancers were common, were less likely to require pneumonectomy, and were associated with better stage-adjusted survival.
METHODS: Two hundred seventy-four patients with NSCLC who underwent surgical resection between 1999 and 2004 were studied. The clinical characteristics of patients with incidentally detected and symptomatic NSCLC were compared. A proportional hazards model was used to compare the stage-adjusted mortality rate of patients with incidentally detected and symptomatic NSCLC.
RESULTS: One hundred patients (36%) had incidentally detected NSCLC. Patients with incidentally detected NSCLC had smaller and earlier-stage cancers, were less likely to undergo pneumonectomy (3% versus 13%, p = 0.005), and were more likely to have bronchioloalveolar carcinoma (15% versus 5%, p = 0.003). Patients with incidentally detected cancers had a stage-adjusted hazards ratio (HR) of mortality of 0.9 compared with symptomatic patients (0.6-1.4, p = 0.64). Patients with cancers detected incidentally on computed tomography (CT) had a stage-adjusted HR of 0.5 (0.2-1.5, p = 0.15).
CONCLUSIONS: Early-stage NSCLC is commonly detected incidentally. Patients with incidentally detected lung cancers are more likely to have bronchioloalveolar carcinoma histology, less likely to undergo pneumonectomy, and overall have similar stage-adjusted survival compared with symptomatic patients. Patients with cancers detected incidentally by CT scan may have better stage-adjusted survival, but our study was not sufficiently powered to detect this effect.

Entities:  

Mesh:

Year:  2007        PMID: 17410027     DOI: 10.1097/jto.0b013e31802f1cb1

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

2.  Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.

Authors:  Jon O Ebbert; Laveena Chhatwani; Marie Christine Aubry; Jason Wampfler; Shawn Stoddard; Fang Zhang; Guibin Qiao; Mariza de Andrade; Ping Yang
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

3.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.

Authors:  Paul L Crispen; Rosalia Viterbo; Stephen A Boorjian; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

4.  Pilot study of a video intervention to reduce anxiety and promote preparedness for lung cancer screening.

Authors:  Dan J Raz; Rebecca A Nelson; Jae Y Kim; Virginia Sun
Journal:  Cancer Treat Res Commun       Date:  2018-04-23

5.  Initial medical attention on patients with early-stage non-small cell lung cancer.

Authors:  Xing Chen; Ivan P Gorlov; Jun Ying; Kelly W Merriman; Marek Kimmel; Charles Lu; Cielito C Reyes-Gibby; Olga Y Gorlova
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

6.  Clinical characteristics and prognosis of incidentally detected lung cancers.

Authors:  S Quadrelli; G Lyons; H Colt; D Chimondeguy; A Buero
Journal:  Int J Surg Oncol       Date:  2015-02-03

7.  Incidental detection by computed tomography is an independent prognostic factor for survival in patients operated for nonsmall cell lung carcinoma.

Authors:  Andri W Orrason; Martin I Sigurdsson; Kristjan Baldvinsson; Hunbogi Thorsteinsson; Steinn Jonsson; Tomas Gudbjartsson
Journal:  ERJ Open Res       Date:  2017-04-27

8.  Differences in lung cancer characteristics and mortality rate between screened and non-screened cohorts.

Authors:  Fu-Zong Wu; Pei-Lun Kuo; Yi-Luan Huang; En-Kuei Tang; Chi-Shen Chen; Ming-Ting Wu; Yun-Pei Lin
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

9.  Prognostic value of symptoms at lung cancer diagnosis: a three-year observational study.

Authors:  Dinora Polanco; Lucía Pinilla; Esther Gracia-Lavedan; Anna Mas; Sandra Bertran; Gemma Fierro; Asunción Seminario; Silvia Gómez; Ferrán Barbé
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.